A phase Ib study of camrelizumab in combination with apatinib and fuzuloparib in patients with recurrent or metastatic triple-negative breast cancer.
9
mentions
- X 7
- YouTube 2
Zhongsheng Tong
PubHawk tracks social media discussions for 1 article by authors named Zhongsheng Tong.
Mentions
9
Peak: 4 in Jan 2023
across 1 tracked article
Extended reach
13,395
potential audience
Total likes
117
Video views
2,949
Mentions per month
Oct 2022 – Jan 2023Where it's discussed
-
X / Twitter7 posts
-
YouTube2 videos
Tracked by PubHawk
Most discussed articles
From PubMed
All publications
Searching PubMed…